Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural kille...
Leadership
Paul J. Hastings
CEO & Director
Nadir Mahmood Ph.D.
President and Principal Accounting & Financial Officer
Shawn Rose M.D., Ph.D.
Chief Medical Officer and Head of Research & Development
